Singapore - English - HSA (Health Sciences Authority)

novartis (singapore) pte ltd - amlodipine besylate 6.94mg (corresponds to amlodipine base); valsartan - tablet, film coated - 5mg - amlodipine besylate 6.94mg (corresponds to amlodipine base) 5mg; valsartan 80mg

Singapore - English - HSA (Health Sciences Authority)

pfizer private limited - amlodipine besylate 6.944mg equivalent to amlodipine; olmesartan medoxomil - tablet, film coated - 5mg - amlodipine besylate 6.944mg equivalent to amlodipine 5mg; olmesartan medoxomil 20mg

Singapore - English - HSA (Health Sciences Authority)

pfizer private limited - amlodipine besylate 13.888mg equivalent to amlodipine; olmesartan medoxomil - tablet, film coated - 10mg - amlodipine besylate 13.888mg equivalent to amlodipine 10mg; olmesartan medoxomil 40mg

Singapore - English - HSA (Health Sciences Authority)

pfizer private limited - amlodipine besylate 6.944mg equivalent to amlodipine; olmesartan medoxomil - tablet, film coated - 5mg - amlodipine besylate 6.944mg equivalent to amlodipine 5mg; olmesartan medoxomil 40mg

Singapore - English - HSA (Health Sciences Authority)

boehringer ingelheim singapore pte. ltd. - amlodipine besilate 13.870mg eqv amlodipine; telmisartan - tablet - 10mg - amlodipine besilate 13.870mg eqv amlodipine 10mg; telmisartan 40mg

Singapore - English - HSA (Health Sciences Authority)

boehringer ingelheim singapore pte. ltd. - amlodipine besilate 6.935 mg eqv amlodipine; telmisartan - tablet - 5mg - amlodipine besilate 6.935 mg eqv amlodipine 5mg; telmisartan 40mg

Singapore - English - HSA (Health Sciences Authority)

boehringer ingelheim singapore pte. ltd. - amlodipine besilate 13.870mg eqv amlodipine; telmisartan - tablet - 10 mg - amlodipine besilate 13.870mg eqv amlodipine 10 mg; telmisartan 80.000mg

Singapore - English - HSA (Health Sciences Authority)

boehringer ingelheim singapore pte. ltd. - amlodipine besilate 6.935mg eqv amlodipine; telmisartan - tablet - 5 mg - amlodipine besilate 6.935mg eqv amlodipine 5 mg; telmisartan 80.000 mg

European Union - English - myHealthbox

astrazeneca ab - metformin hydrochloride, dapagliflozin propanediol monohydrate - film-coated tablet (tablet) - 5 mg/850 mg - diabetes mellitus, type 2 - drugs used in diabetes, combinations of oral blood glucose-lowering drugs - indicated in adults aged 18 years and older with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycaemic control - in patients inadequately controlled on their maximally tolerated dose of metformin alone - in combination with other glucose-lowering medicinal products, including insulin, in patients inadequately controlled with metformin and these medicinal products - in patients already being treated with the combination of dapagliflozin and metformin as separate tablets

European Union - English - myHealthbox

astrazeneca ab - metformin hydrochloride, dapagliflozin propanediol monohydrate - film-coated tablet (tablet) - 5 mg/1,000 mg - diabetes mellitus, type 2 - drugs used in diabetes, combinations of oral blood glucose-lowering drugs - indicated in adults aged 18 years and older with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycaemic control - in patients inadequately controlled on their maximally tolerated dose of metformin alone - in combination with other glucose-lowering medicinal products, including insulin, in patients inadequately controlled with metformin and these medicinal products - in patients already being treated with the combination of dapagliflozin and metformin as separate tablets